Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil S Ghadyalpatil

Showing results (1-10 of 1) with videos related to

Pageof 1
Sort By:
Ecancermedicalscience|March 5, 2024
Real world study of safety and efficacy of lorlatinib as second line and beyond in <i>ALK</i>-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND)Bivas Biswas, Nikhil S Ghadyalpatil, Shekar Patil, et al.
Pageof 1

Showing results (1-10 of 1) with videos related to

Sort By:
Pageof 1
Ecancermedicalscience|March 5, 2024
Real world study of safety and efficacy of lorlatinib as second line and beyond in <i>ALK</i>-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND)Bivas Biswas, Nikhil S Ghadyalpatil, Shekar Patil, et al.
Pageof 1